BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34100060)

  • 21. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.
    Demissei BG; Cotter G; Prescott MF; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Severin TM; Wang Y; Qian M; Teerlink JR; Metra M; Davison BA; Voors AA
    Eur J Heart Fail; 2017 Aug; 19(8):1001-1010. PubMed ID: 28133908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction.
    Thune JJ; Signorovitch JE; Kober L; McMurray JJ; Swedberg K; Rouleau J; Maggioni A; Velazquez E; Califf R; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2011 Feb; 13(2):148-53. PubMed ID: 21037250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma tumour necrosis factor-alpha-related proteins in prognosis of heart failure with pulmonary hypertension.
    Engel Sällberg A; Helleberg S; Ahmed S; Ahmed A; Rådegran G
    ESC Heart Fail; 2023 Dec; 10(6):3582-3591. PubMed ID: 37772417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proenkephalin and prognosis after acute myocardial infarction.
    Ng LL; Sandhu JK; Narayan H; Quinn PA; Squire IB; Davies JE; Bergmann A; Maisel A; Jones DJ
    J Am Coll Cardiol; 2014 Jan; 63(3):280-9. PubMed ID: 24140658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton C; Turner J; Crozier IG; Yandle TG
    Circulation; 2003 Jun; 107(22):2786-92. PubMed ID: 12771003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction.
    Hjort M; Eggers KM; Lindhagen L; Baron T; Erlinge D; Jernberg T; Marko-Varga G; Rezeli M; Spaak J; Lindahl B
    Clin Biochem; 2021 Dec; 98():17-23. PubMed ID: 34496288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting outcome in patients with acute coronary syndrome: evaluation of B-type natriuretic peptide and the global registry of acute coronary events (GRACE) risk score.
    Sinclair H; Paterson M; Walker S; Beckett G; Fox KA
    Scott Med J; 2007 Aug; 52(3):8-13. PubMed ID: 17874709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction.
    Onoue K; Uemura S; Takeda Y; Somekawa S; Iwama H; Nishida T; Morikawa Y; Nakagawa H; Tsutsumi T; Sung JH; Takemoto Y; Soeda T; Okayama S; Ishigami K; Kawata H; Horii M; Nakajima T; Saito Y
    Am J Cardiol; 2009 Dec; 104(11):1478-83. PubMed ID: 19932778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of short-term follow-up B-type natriuretic peptide levels after hospital discharge in patients with acute myocardial infarction.
    Lee JW; Choi E; Khanam SS; Son JW; Youn YJ; Ahn MS; Ahn SG; Kim JY; Lee SH; Yoon J; Yoo BS
    Int J Cardiol; 2019 Aug; 289():19-23. PubMed ID: 30638981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive assessment of left ventricular filling pressure after acute myocardial infarction: a prospective study of the relative prognostic utility of clinical assessment, echocardiography, and B-type natriuretic peptide.
    Kruszewski K; Scott AE; Barclay JL; Small GR; Croal BL; Møller JE; Oh JK; Hillis GS
    Am Heart J; 2010 Jan; 159(1):47-54. PubMed ID: 20102866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.
    Khanam SS; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Yoo BS
    BMC Cardiovasc Disord; 2017 Aug; 17(1):215. PubMed ID: 28774268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW
    Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multiplex analysis on the luminex platform in complex estimation of cardiovascular biomarker dynamics in patients with acute myocardial infarction.].
    Gusakova AM; Suslova TE; Ryabov VV; Kercheva MA
    Klin Lab Diagn; 2019; 64(9):525. PubMed ID: 31610103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes.
    Omland T; Persson A; Ng L; O'Brien R; Karlsson T; Herlitz J; Hartford M; Caidahl K
    Circulation; 2002 Dec; 106(23):2913-8. PubMed ID: 12460871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of TNF-related apoptosis inducing ligand (TRAIL) in acute coronary syndrome patients.
    Osmancik P; Teringova E; Tousek P; Paulu P; Widimsky P
    PLoS One; 2013; 8(2):e53860. PubMed ID: 23441146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential clinical application of novel cardiac biomarkers for acute myocardial infarction.
    Nursalim A; Suryaatmadja M; Panggabean M
    Acta Med Indones; 2013 Jul; 45(3):240-50. PubMed ID: 24045397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
    J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Natriuretic peptides and multimarker approach to risk stratification of patients with acute coronary syndromes].
    Matunović R; Stojanović A; Mijailović Z; Cosić Z
    Med Pregl; 2006; 59(5-6):248-52. PubMed ID: 17039908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.